4-153788745-G-C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_003013.3(SFRP2):​c.91C>G​(p.Pro31Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000036 in 1,613,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00023 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

SFRP2
NM_003013.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.06
Variant links:
Genes affected
SFRP2 (HGNC:10777): (secreted frizzled related protein 2) This gene encodes a member of the SFRP family that contains a cysteine-rich domain homologous to the putative Wnt-binding site of Frizzled proteins. SFRPs act as soluble modulators of Wnt signaling. Methylation of this gene is a potential marker for the presence of colorectal cancer. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.04327196).
BS2
High AC in GnomAd4 at 35 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SFRP2NM_003013.3 linkc.91C>G p.Pro31Ala missense_variant Exon 1 of 3 ENST00000274063.5 NP_003004.1 Q96HF1A0A140VJU3B3KSM5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SFRP2ENST00000274063.5 linkc.91C>G p.Pro31Ala missense_variant Exon 1 of 3 1 NM_003013.3 ENSP00000274063.4 Q96HF1

Frequencies

GnomAD3 genomes
AF:
0.000230
AC:
35
AN:
152228
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000323
AC:
8
AN:
247466
AF XY:
0.0000223
show subpopulations
Gnomad AFR exome
AF:
0.000456
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000157
AC:
23
AN:
1460752
Hom.:
0
Cov.:
35
AF XY:
0.0000151
AC XY:
11
AN XY:
726710
show subpopulations
Gnomad4 AFR exome
AF:
0.000448
AC:
15
AN:
33480
Gnomad4 AMR exome
AF:
0.0000447
AC:
2
AN:
44724
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
26132
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
0.00
AC:
0
AN:
86254
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
52342
Gnomad4 NFE exome
AF:
0.00000180
AC:
2
AN:
1111990
Gnomad4 Remaining exome
AF:
0.0000662
AC:
4
AN:
60380
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000230
AC:
35
AN:
152346
Hom.:
0
Cov.:
32
AF XY:
0.000228
AC XY:
17
AN XY:
74504
show subpopulations
Gnomad4 AFR
AF:
0.000721
AC:
0.000721466
AN:
0.000721466
Gnomad4 AMR
AF:
0.000196
AC:
0.000196027
AN:
0.000196027
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.0000294
AC:
0.0000293927
AN:
0.0000293927
Gnomad4 OTH
AF:
0.00
AC:
0
AN:
0
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000238
ESP6500AA
AF:
0.000909
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 09, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.91C>G (p.P31A) alteration is located in exon 1 (coding exon 1) of the SFRP2 gene. This alteration results from a C to G substitution at nucleotide position 91, causing the proline (P) at amino acid position 31 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
18
DANN
Benign
0.75
DEOGEN2
Benign
0.36
T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.18
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.71
T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.043
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
2.0
M
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.11
Sift
Benign
0.63
T
Sift4G
Benign
1.0
T
Polyphen
0.29
B
Vest4
0.32
MVP
0.72
MPC
0.74
ClinPred
0.047
T
GERP RS
2.7
Varity_R
0.12
gMVP
0.59
Mutation Taster
=69/31
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144480119; hg19: chr4-154709897; API